title: Questions and answers in the management of primary central nervous system and ocular lymphomas.
authors.affiliation: Department of Radiochemotherapy, San Raffaele H Scientific Institute, via Olgettina 60, 20132 Milan, Italy. ferreri.andres@hsr.it
authors.forename: Andrés J M
authors.initials: AJ
authors.lastname: Ferreri
authors.forename: Stefania
authors.initials: S
authors.lastname: Dell'oro
authors.forename: Michele
authors.initials: M
authors.lastname: Reni
authors.forename: Marco
authors.initials: M
authors.lastname: Foppoli
authors.forename: Nicoletta
authors.initials: N
authors.lastname: Anzalone
authors.forename: Silvia
authors.initials: S
authors.lastname: Govi
authors.forename: Piero
authors.initials: P
authors.lastname: Picozzi
authors.forename: Giulio
authors.initials: G
authors.lastname: Truci
authors.forename: Maurilio
authors.initials: M
authors.lastname: Ponzoni
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016543:Central Nervous System Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D003131:Combined Modality Therapy / Q000379:methods / Q000639:trends; D000075202:Contraindications; D005134:Eye Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy* / Q000532:radiotherapy*